Mapping posttranslational modifications (PTMs), which diversely modulate biological functions, represents a significant analytical challenge. The centerpiece technology for PTM site identification, mass spectrometry (MS), requires proteolytic cleavage in the vicinity of a PTM to yield peptides for sequencing. This requirement catalyzed our efforts to evolve MS-grade mutant PTM-directed proteases. Citrulline, a PTM implicated in epigenetic and immunological function, made an ideal first target, because citrullination eliminates arginyl tryptic sites. Bead-displayed trypsin mutant genes were translated in droplets, the mutant proteases were challenged to cleave bead-bound fluorogenic probes of citrulline-dependent proteolysis, and the resultant beads (1.3 million) were screened. The most promising mutant efficiently catalyzed citrulline-dependent peptide bond cleavage (k cat /K M = 6.9 × 10 5 M
Mapping posttranslational modifications (PTMs), which diversely modulate biological functions, represents a significant analytical challenge. The centerpiece technology for PTM site identification, mass spectrometry (MS), requires proteolytic cleavage in the vicinity of a PTM to yield peptides for sequencing. This requirement catalyzed our efforts to evolve MS-grade mutant PTM-directed proteases. Citrulline, a PTM implicated in epigenetic and immunological function, made an ideal first target, because citrullination eliminates arginyl tryptic sites. Bead-displayed trypsin mutant genes were translated in droplets, the mutant proteases were challenged to cleave bead-bound fluorogenic probes of citrulline-dependent proteolysis, and the resultant beads (1.3 million) were screened. The most promising mutant efficiently catalyzed citrulline-dependent peptide bond cleavage (k cat /K M = 6.9 × ). The resulting C-terminally citrullinated peptides generated characteristic isotopic patterns in MALDI-TOF MS, and both a fragmentation product y 1 ion corresponding to citrulline (176.1030 m/z) and diagnostic peak pairs in the extracted ion chromatograms of LC-MS/MS analysis. Using these signatures, we identified citrullination sites in protein arginine deiminase 4 (12 sites) and in fibrinogen (25 sites, two previously unknown). The unique mass spectral features of PTM-dependent proteolytic digest products promise a generalized PTM site-mapping strategy based on a toolbox of such mutant proteases, which are now accessible by laboratory evolution.
posttranslational modification | proteomics | directed evolution | protease | in vitro compartmentalization T he identification and mapping of protein posttranslational modifications (PTMs), which underpin the regulation of virtually every cellular function, represents one of the most significant challenges of modern-day analytical science. Accessing this biochemical information requires direct observation of the modified site, often in low abundance within the complex cellular milieu. The ability to address this sample complexity is precisely why tandem mass spectrometry (MS/MS) now dominates proteomic analysis. LC-MS/MS instruments can analyze mixtures of thousands of peptides, acquiring the mass-to-charge ratio (m/z) of each peptide precursor ion (MS1) and fragmenting the most abundant precursors for a second dimension of MS analysis (MS2). Database searching of MS/MS "bottom-up" proteomic data entails matching observed precursor and fragmentation product ion masses with those of a theoretical protein digest, returning the amino acid sequence of each ion (including any PTMs) and statistical confidence of the sequence match (1, 2).
Bottom-up MS/MS workflows generate peptides for analysis almost ubiquitously by digestion using trypsin, which cleaves the C-terminal peptide bonds of Arg and Lys with high catalytic efficiency and selectivity (3) . Regions of a protein too densely or too sparsely populated with tryptic sites result in sequencing coverage gaps, which can conceal PTM sites during mapping experiments. Digestion with alternative proteases (4, 5) , which reinforce tryptic cleavage efficiency or introduce cleavages at nontryptic sites, enhance coverage by increasing the probability that more regions of the protein will be represented in peptides appropriate for MS analysis. However, only a handful of naturally occurring enzymes exists, and they suffer myriad drawbacks, such as extreme cleavage site promiscuity or low catalytic efficiency (6) .
The relationship between protein cleavage and MS sequence coverage has spurred the exploration of methods to induce alternate cleavages, especially at PTM sites. Examples include chemoselective pSer side chain modification to establish pSer-dependent tryptic cleavage sites (7, 8) , and directed evolution of novel proteolytic cleavage activity, yielding a pTyr-dependent subtilisin mutant (9) and a suite of OmpT mutants that cleaved the Ala-Arg (10), sTyr-Arg (11), or nTyr-Arg (12) P1-P1′ peptide bonds; P1-P1′ cleavage junction requirements precluded further implementation. Proteolytic specificity has also been successfully evolved in other enzymes (13, 14) , but the MS workhorse enzyme, trypsin, has remained unexplored. Although the trypsin family is the textbook example of divergent evolution (the highly homologous family members possess diverse cleavage specificities), its network of specificity-determining residues-a constellation of approximately four point mutations (15) (16) (17) and two 4-residue surface-exposed loops (18)-is daunting. Evolution would require large libraries and either a high-throughput mutant screening or selection approach (19) to discover new cleavage specificity. We sought to develop such an approach in the light of trypsin's compelling phylogeny and the promise of PTMdirected proteases for proteomics, and pursued the evolution of proteolytic specificity targeting the PTM citrulline.
Citrullination, the product of protein arginine deiminase (PAD)-mediated deimination of key Arg side chains, is important in an array of epigenetic (20) and immunological functions (21) , but detecting citrullination by MS is problematic. Citrullination eliminates tryptic sites, resulting in larger peptides that are harder to detect and sequence. Further, deamidation of Gln or Asn produces mass shifts identical to citrullination. Several chemical proteomic strategies aid in the identification of citrullinated peptides (22) (23) (24) (25) , but citrulline site identifications particularly (and PTM site identifications generally) require observation of an ion series containing Significance Protein posttranslational modifications (PTMs) regulate virtually every aspect of cellular function. Mapping PTMs is a key application of protein mass spectrometry (MS), which analyzes thousands of peptides generated in enzymatic protein digests. There are currently only about seven naturally occurring proteases for generating these digests, and with the exception of trypsin, most are poor or promiscuous enzymes that are not ideal for MS. This protease "toolbox" has remained essentially unchanged for decades. In this study, the directed evolution of trypsin's proteolytic specificity resulted in the discovery of a mutant protease that efficiently cleaves at citrullinated arginines, affording a powerful PTM site identification tool and promising a Darwinian wellspring of new, custom proteases. the PTM-added mass in the MS2 spectrum. For example, if the fourth residue of a 10-residue peptide is modified, all fragmentation ions should reflect the PTM's added mass in the b series b 4 -b 9 and y series y 7 -y 9 (the b i ion is the N-terminal product of fragmentation at the i th amide bond counted from the N terminus; the y i ion is the C-terminal product of fragmentation at the i th amide bond counted from the C terminus) (26) . A citrulline-dependent (or, generally, PTM-dependent) protease, however, would generate peptides with a C-terminally citrullinated (modified) residue, and MS2 spectra of all such citrulline-terminated peptides should feature a y 1 ion corresponding to the mass of citrulline.
Results
Compartmentalized Evolution of a Citrulline-Dependent Protease.
We devised a compartmentalized microbead display (27, 28) strategy for high-throughput mutant protease expression and activitybased screening. Activity assay "probe-primer" beads ( Fig. 1 , Upper) display an oligonucleotide PCR primer and a bisamide rhodamine 110 (R110) protease activity assay probe (Figs. S1-S3) (29) . Probeprimer beads and a trypsinogen mutant gene library were used in emulsion PCR (emPCR) to generate beads clonally populated with ∼10,000 copies of a gene library member (probe-gene beads) (30) followed by emulsion in vitro transcription/translation (emIVTT) for highly parallel, low-volume protein expression and activity assay. FACS analysis isolated single beads encoding active proteases that dequenched bead-bound R110 probes ( Fig. 1, Lower) .
Control tryptic probe-primer beads displaying (acGPR) 2 R110 that were digested with MS-grade or translated and enterokinase (EK)-activated trypsin and analyzed by flow cytometry exhibited good separation from untreated and unfunctionalized beads ( Fig. 2A) . With feasibility established, citrulline-dependent activity assay probe-primer beads displaying (acIPcit) 2 R110 were elaborated with an EGGK(185-188)XXXX/D189S trypsinogen mutant library. This library explored the active site-proximal specificity-determining surface-exposed loop 1 (18) in the context of a fixed D189S (31), another key residue in the base of the active site that we also found to confer basal citrulline-dependent cleavage activity (Fig. S4 ). emIVTT and FACS screening of 1.3 × 10 6 (acIPcit) 2 R110 probe-gene library beads yielded 53 events (Fig. 2B ), 21 successful sorts to individual quantitative PCRs (qPCRs), and 15 clean amplifications. One sample exhibited enhanced citrullinedependent proteolysis in a "real-time" IVTT activity assay ( Fig. 2C ) (32) . The screening lead contained the citrulline-active loop 1 mutant EGGK(185-188)KGGA and one additional serendipitous mutation, L7P, in the posttranslationally cleaved N-terminal propeptide. The L7P mutation conferred no detectable citrulline-dependent cleavage activity to trypsin by real-time IVTT assay, although L7P increased real-time IVTT reaction progress of trypsin using a tryptic substrate. Screening of either loop 2 QKNK(221-224)XXXX or rescreening loop 1 with fixed L7P did not yield more compelling leads, though L7P modestly increased the hit rate (Fig. S4) . The confirmed mutant L7P/EGGK(185-188)KGGA/D189S was declared trypsin +cit to reflect its trypsin ancestry and citrullinedependent activity. = 11,658 after activation (active enzyme). Overexpression of wild-type trypsin was unsuccessful under otherwise identical conditions. Installation of L7P alone onto trypsin was sufficient to generate overexpression product by SDS/PAGE, and the P7L trypsin +cit revertant abolished overexpression product (Fig. S4) .
Digestion of fluorogenic peptide probes (Fig. 3) , black hole quencher (BHQ)-IPcitAA-fluorescein (FAM) and BHQ-IPRAAtetramethylrhodamine (TMR) (Fig. S5) , with trypsin, trypsin +cit , or an activator control (EK) and fluorescence monitoring confirmed specific enzyme activities on more conventional substrates: after 2+ m/z) in the respective XICs, whereas the tryptic digest XIC contained new N-and C-terminal products of cleavage at Arg (1,030.58 + and 962.33 + m/z, respectively); the C-terminal fragment exists as three regioisomeric TMR coupling products, which are chromatographically distinct but otherwise indistinguishable by MS (Fig. S6) . Trypsin +cit exhibited greatly enhanced citrulline-dependent activity in steady-state kinetic analyses. . Tryptic cleavage of BHQ-IPcitAA-FAM was undetectable (Fig. S7) . . Blank beads (white) were significantly less fluorescent than either undigested tryptic probe-primer beads (gray, 1,500 ± 400) or trypsin-digested beads (cyan, 3,100 ± 600). Incubation of the tryptic probe-primer beads displaying trypsinogen-encoding DNA templates and EK in IVTT mixture (Lower) resulted in increased bead fluorescence of IVTT trypsin-digested beads (cyan, ∼40 solution-phase trypsinogen template molecules/bead yielding ∼3,000 protease molecules/bead, signal shifted to 2,100 ± 500) relative to probe-primer beads exposed to IVTT alone (gray).
(B) emIVTT and FACS analysis of a trypsinogen EGGK(185-188)XXXX/D189S mutant gene library amplified on (acIPcit) 2 R110 probe-primer beads yielded a hit pool of 53 beads (orange) that exhibited ∼eightfold enhanced fluorescence over negative control beads (dark gray), cleanly shifted from the uncollected 1.3 × 10 6 events (light gray). (C) Individual hit beads from FACS were amplified and the PCR products analyzed in real-time IVTT assays containing either tryptic probe (cbzIPR) 2 R110 (Arg) or citrulline-specific screening probe (acIPcit) 2 R110 (cit). Activity traces include the wild-type trypsinogen gene (cyan), gene library (green), most promising screening hit (orange), and negative control (gray).
Fig. 3. Fluorogenic peptide digestion and LC-MS analysis. (A) Both fluorogenic substrates contained a BHQ quencher (purple)
. The cit-containing probe was C-terminally labeled with FAM (green) and the Arg-containing probe was C-terminally labeled with TMR (yellow). The digest schematics display the doubly charged full-length peptide ion and singly charged enzymatic digest product theoretical exact masses. (B) Digests of both peptides were performed using trypsin +cit (Upper), EK control (Middle), or trypsin (Lower). XIC retention times differ for the full-length (gray), BHQ-labeled N-terminal fragment (purple), FAM-labeled citrulline-dependent C-terminal cleavage product (green), and TMR-labeled tryptic C-terminal cleavage products (yellow). Observed m/z and ion charge state appear above each XIC peak. The intensity of each C-terminal digest product XIC is magnified 6×. -treated PAD4) (33) produced notably different MALDI-TOF MS spectra, which were also dramatically different from feature-poor spectra of tryptic digests. Qualitatively, the tryptic digest spectra of PAD4 and adPAD4 are nearly identical (Fig. S8) . However, trypsin +cit digestion of adPAD4 produced numerous new features (428 vs. 173 with S/N > 3.5, intensity > 5% base peak). A magnified view displays two example features unique to the PAD4 and adPAD4 trypsin +cit digest (Fig. 4) . The 1,387 m/z ion (534-TLREHNSFVER-544) was prevalent in both PAD4 and adPAD4 trypsin +cit digests, yet undetectable in the tryptic digest. The peptide's sequence yielded its molecular formula and thereby the theoretical abundance of each isotopic peak based on the binomial distribution and natural abundances of each element. The theoretical and observed isotopic envelopes agreed for both PAD4 and adPAD4 versions of the 1,387 m/z ion. The isotopic envelope of the 1,400 m/z ion (363-TLPVVFDSPRNR-374), another new trypsin +cit feature, agreed with the expected theoretical envelope. The same feature in the adPAD4 spectrum contained a low-intensity molecular ion and high-intensity first isotope, inconsistent with the expected theoretical envelope for a peptide of this mass where the highest intensity peak should be the molecular ion; instead, it agreed more closely with the overlapping envelopes of two peptides whose molecular ions are shifted by ∼1 Da, suggesting the presence of an unmodified and citrullinated (Δm = 0.984 Da) form of the same peptide.
LC-MS/MS investigation of the adPAD4 trypsin +cit digest confirmed citrullination of the 1,400 m/z peptide and revealed other diagnostic signatures of citrullination. Database matching (34) returned 53 unique peptides from the tryptic adPAD4 digest (24 peptides contained C-terminal Arg) and 91 unique peptides from the trypsin +cit digest (34 peptides contained C-terminal Arg). The 1387 m/z ion (534-TLREHNSFVER-544) appeared in both tryptic and trypsin +cit digest analyses, the XIC contained only one chromatographic peak (463.5687 3+ m/z), and the MS1 isotopic envelope agreed with the unmodified mass. In contrast, the XIC of the 1,400 m/z ion (Fig. 5, Upper) Trypsin +cit digestion of native fibrinogen alpha, beta, and gamma chains (FGA, FGB, FGG) and PAD4-citrullinated fibrinogen (cFGA, cFGB, cFGG) produced analogous citrullination-dependent mass spectral signatures. The novel trypsin +cit cleavages increased sequence coverage compared with the tryptic digest for the heavily modified cFGA chain (68% vs. 52% in the tryptic digest), as well as for cFGB and cFGG chains (88% vs. 77% and 78% vs. 75%, respectively; Fig. S9 ). Mascot (34) and X!Tandem (35) database searches of the two LC-MS/MS analyses (trypsin or trypsin +cit digestion of cFG) generated two lists of peptides for filtering via direct assignment of Arg modification, y 1 (cit) detection, or both (Fig. 6, Upper) . The MS2 fragmentation product ion y 1 (cit) is a unique feature of all C-terminally citrullinated peptides, though not all sites of citrullination were assigned as a result of a C-terminal citrulline; some sites were internal in the trypsin +cit sample. All citrullinated sites were observed internal in the tryptic digest. The larger sequence space of cFG also allowed an analysis of trypsin +cit cleavage junction P1 and P1′ residues. In addition to citrulline, Arg and Lys were the most common P1 residues. Cleavage products also frequently contained C-terminal Tyr and Gln (Fig. 6, Lower) . The P1′ residue profile of trypsin +cit and trypsin are fairly similar. P1′ Pro and Trp appeared to be particularly disfavored.
XIC analysis of the cFG trypsin +cit digest peptides (modified and unmodified forms) that appeared in both database searches (Mascot and X!Tandem) as citrullinated usually resulted in only a single chromatographic peak corresponding to the modified form (Fig. S10) . XIC analysis of FG trypsin +cit digest peptides yielded peaks corresponding to the unmodified form of the peptide for most sites. The cFG trypsin +cit digest yielded 49 unique peptides that cross-validated between two database searches as containing a deiminated Arg. Among the 18 FGA sites, 12 contained y1(cit) and 1 was previously unreported (R621). Among the 6 FGB sites, 1 contained y1(cit) and 1 was previously unreported (R376). For the 1 FGG site, y1(cit) was not detected. Previously identified citrullination sites not sequenced by trypsin +cit included seven in FGA (287, 308, 353, 367, 394, 404, 425) , four in FGB (121, 124, 285, 410), and two in FGG (40, 282 
Discussion
Trypsin's high activity, solubility, and ancestry of divergent proteolytic specificity make it a promising scaffold for evolution. However, trypsin possesses six nonconsecutive disulfide bonds and it is translated as a zymogen that requires posttranslational proteolytic cleavage of an N-terminal propeptide to produce the mature enzyme, presenting significant challenges for conventional protein evolution involving recombinant expression. Supplementing IVTT to promote S-S bond formation, folding, and propeptide proteolysis sidestepped the throughput limitations of recombinant expression, but the cost of IVTT reagent and complexity of libraries containing all possible loop sequences required the much higher throughput and miniaturization of compartmentalized evolution (27) .
Screening for citrulline-dependent proteolytic activity yielded trypsin +cit , an efficient citrulline-dependent mutant. In addition to the expected reconfiguration of loop 1, another mutation, L7P, was observed in the posttranslationally cleaved N-terminal propeptide signal sequence. That L7P alone was required for bacterial overexpression of both trypsin and trypsin +cit cast doubt on its role in the evolution of novel proteolytic specificity. Exogenous proteins possessing signal peptides are known to enter the secretion pathway, but are rapidly degraded (37); a single Leu-to-Pro mutation of the signal peptide hydrophobic region completely disrupts signal peptide function, restores cytosolic expression, and increases protein synthesis in vitro (38) (39) (40) . These findings inform future library design, because L7P will be both advantageous for IVTT yield and convenient for moving screening hits directly into recombinant expression.
Deployment of trypsin +cit in standard MS proteomics analyses of PAD4 and fibrinogen as case studies revealed unique signatures of modification. Trypsin +cit analysis of PAD4, which catalyzes the deimination of other proteins and itself (33, 41) , definitively mapped 12 sites of citrullination based on detection of y 1 (cit), a signature of fragmenting C-terminally citrullinated peptides at the C-terminal amide bond. XIC analysis detected 11 of the 12 peptides as pairs of both modified and unmodified versions, providing additional site discovery confirmation. Fibrinogen is a target of PAD4 activity that exists as three chains, one of which (FGA) is extensively modified. Trypsin +cit also identified the majority of known citrullination sites in cFG. Both case studies successfully demonstrated y 1 (PTM) detection, setting the stage for a generalized approach to PTM discovery. PTM-dependent enzymatic cleavage and the resulting y 1 (PTM) Deiminated Arg sites in the trypsin +cit digest are the result of either y 1 (cit) ion detection and database matching (dark orange, white R) or database matching alone (dark orange, black R). The fraction of identified cleavage junctions in the tryptic (cyan) and trypsin +cit (orange) digests of cFGA, cFGB, and cFGG is plotted by P1 residue. Trypsin +cit cleavages at cit, Gln, and Tyr are each >15% total cleavages. The majority of trypsin +cit cleavages derive from its ancestral Arg-and Lys-directed activity. A similar analysis of cleavage junction P1′ residues revealed little preference for either enzyme.
could enable selected reaction monitoring (SRM) beyond MS-labile modifications, such as phosphorylation (42), with transition detection unambiguously assigning the modification site to the terminus. This study predicts such y 1 (PTM) SRM experiments will not require an enzyme with high cleavage selectivity for the PTM over other residues. The enzyme must simply generate the cleavages efficiently and with appropriate frequency, and the PTM must generate a detectable y 1 fragment. Of course, these experiments are incumbent upon using the present approach to evolve other proteases, a prospect proposed more than a decade ago (8) . Real-Time IVTT Assay. Purified PCR product from single-bead amplifications (5 ng) or plasmid template (22 ng) was added to IVTT reactions (5 μL, above) and either (acIPcit) 2 R110 (3 μM) or (cbzIPR) 2 R110 (3 μM). Reactions were incubated (37°C, 1,000 min) with fluorescence monitoring (channel 1, CFX96; Bio-Rad).
Methods
Detailed methods are available in SI Methods.
